For now, Primatene mist can be used instead used instead of Albuterol for an asthma attack. However, the FDA recently voted to recommend Primatene mist to be taken off the market, creating uncertainties about its future.
Primatene Mist is a trade name for an epinephrine metered-dose inhaler sold over-the-counter in the United States for the relief of bronchial asthma. It was manufactured by Armstrong Pharmaceuticals, a company based in Canton, Massachusetts and a subsidiary of Amphastar Pharmaceuticals, located in Rancho Cucamonga, California.
Because Primatene Mist contained chlorofluorocarbon, it can no longer be prescribed or sold. This ban was unsuccessfully challenged in the United States Senate in November 2011. An exception to this ban was proposed for inhalers, but due to extensive lobbying by pharmaceutical companies looking to drive cheap inhalers off the market, so as to protect their newly patented alternatives, the ban remains in place. FDA
A Respiratory Therapist is specialized healthcare practitioner who has graduated from a college or a university and passed a national board certifying examination. Respiratory therapists work under the general supervision of a primary provider, such as physician or nurse practitioner most often in intensive care and operating rooms, but also in outpatient clinics.
Respiratory therapists are specialists and educators in cardiology and pulmonology. Respiratory therapists are also advanced-practice clinicians in airway management; establishing and maintaining the airway during management of trauma, intensive care, and may administer anaesthesia for surgery or conscious sedation.
Lower respiratory tract infection, while often used as a synonym for pneumonia, can also be applied to other types of infection including lung abscess and acute bronchitis. Symptoms include shortness of breath, weakness, high fever, coughing and fatigue.
Lower respiratory tract infections place a considerable strain on the health budget and are generally more serious than upper respiratory infections. Since 1993 there has been a slight reduction in the total number of deaths from lower respiratory tract infection. However in 2002 they were still the leading cause of deaths among all infectious diseases, and they accounted for 3.9 million deaths worldwide and 6.9% of all deaths that year. Phenethylamines
Legend of Legaia (レガイア伝説 Regaia Densetsu) is a 1998 Sony PlayStation role-playing video game created by Contrail. The game was followed by a 2001 sequel video game, Legaia 2: Duel Saga for the PlayStation 2 which is rather than continuing the first game's storyline and provides an original story set in the homonymous Legaia.
Health Medical Pharma